Gut Liver.
2022 May;16(3):319-320. 10.5009/gnl220183.
Waiting for Multi-Stakeholders ̕ Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature
- Affiliations
-
- 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
- KMID: 2529839
- DOI: http://doi.org/10.5009/gnl220183
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Waiting for the changes after the adoption of steatotic liver disease
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
- Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
